Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of OPC-262 (Saxagliptin) in Type 2 Diabetes
NCT00857558Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Kyowa Kirin. Started Jan 2009; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00857558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857558.